Showing 35,658 results

Chemsex & recreational drug use

Changes to UK Steroid Laws

Editor's pick
Injecting Advice
23 April 2012
Epidemiology & behaviour

Study: Craigslist Drives STD Spread

Editor's pick
Investor Place
23 April 2012
Condoms & lubricant

The Female Health Company to Expand Manufacturing Capacity for FC2 Female Condoms

Editor's pick
MarketWatch (press release)
23 April 2012
The search for an HIV prevention vaccine

Shingles vaccine is safe, according to new study

Editor's pick
Eurekalert Medicine & Health
23 April 2012
New & experimental hepatitis C treatment

Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
New & experimental hepatitis C treatment

Achillion Clarifies End of Treatment Data From Phase 2a Trial With ACH-1625 Based Regimen in Hepatitis C

Editor's pick
Achillion (press release)
23 April 2012
HIV & criminal law

Is Criminalization of HIV Transmission Effective? Swedish Case Reveals Why the Why the Answer is No

Editor's pick
RH Reality Check
23 April 2012
PrEP

The 100 Most Influential People in the World: Robert Grant

Editor's pick
Time
23 April 2012
New & experimental hepatitis C treatment

Adding TMC435 boosts response for difficult-to-treat hepatitis C patients

News
23 April 2012
New & experimental hepatitis C treatment

Hepatitis C drug alisporivir is effective, but pancreatitis a concern

News
23 April 2012
PrEP science

PrEP acceptable to UK gay men, studies find

News
21 April 2012
Access to healthcare

Kenya: UNAIDS welcomes High Court judgment on anti-counterfeit law

Editor's pick
UNAIDS
20 April 2012
Hepatitis C treatment side-effects

Telaprevir and boceprevir show high rate of serious side-effects in hepatitis C patients with urgent need of treatment

News
20 April 2012
New & experimental hepatitis C treatment

Hepatitis C meds GS-7977, daclatasvir and asunaprevir look good in interferon-free combos

News
20 April 2012
New & experimental hepatitis C treatment

J&J Open to Expanding Hepatitis C Collaboration With Vertex

Editor's pick
HCV New Drugs Research
20 April 2012
New & experimental hepatitis C treatment

Interferon-lambda as effective as alpha but with much better safety profile in hepatitis C

News
20 April 2012
New & experimental hepatitis C treatment

Pancreatitis Forces Halt to HCV Drug Trial

Editor's pick
MedPage Today
20 April 2012
New & experimental hepatitis C treatment

Janssen Creates new Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA

Editor's pick
Janssen press release
20 April 2012
Undetectable viral load & treatment as prevention

Guidance on couples HIV testing and counselling, including antiretroviral therapy for treatment and prevention in serodiscordant couples

Editor's pick
World Health Organization
20 April 2012
New & experimental hepatitis C treatment

No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine & Etravirine

Editor's pick
NATAP
20 April 2012
New & experimental HIV treatments

Cobicistat Doubles to Triples Exposure of GS-7340 (a Tenofovir Prodrug) and Resulting Tenofovir

Editor's pick
NATAP
20 April 2012
New & experimental hepatitis C treatment

Gilead’s Experimental Hepatitis C Drug Cured 88% Post-Therapy

Editor's pick
Bloomberg
20 April 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial

Editor's pick
Bloomberg
20 April 2012
New & experimental hepatitis C treatment

Medivir Hep C Drug Cures 80% of Patients Post-Treatment

Editor's pick
Bloomberg BusinessWeek
20 April 2012